International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released May 14, 2026, after the close
10-Q filed May 14, 2026, 44 days after period end · 0001193125-26-223926
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $2.32M | $2.13M | $2.13M | $2.09M |
| Net Income | -$220.00K | -$256.00K | -$214.00K | -$34.00K |
| EPS Diluted | -$0.03 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.03 |
| -$0.03 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
